Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients
Clinical trial NCT05213221 · COMPLETED
Trial details
- NCT number
- NCT05213221
- Sponsor
- Zhejiang University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2022-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.